Our experiments with shRNA and siRNAs showed the function of SET as an inducer of cell proliferation (by activating AKT and ERK pathways), and as an inhibitor of apoptosis in AML cells, through its binding and inhibition of PP2A. The gene discussed is AKT1; the disease is acute myeloid leukemia.